Genetic Technologies Announces Closing of US$2 Million Registered Direct Offering
Genetic Technologies Ltd - American Depositary Shares (GENE)
US:NASDAQ Investor Relations:
gtgcorporate.com/investor-centre
Company Research
Source: GlobeNewswire
MELBOURNE, Australia, April 23, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, “Company”, “GTG”, or “Genetic Technologies”), a global leader in guideline-driven genomics-based tests in health, wellness and serious diseases, today announces the closing of its previously announced registered offering for the purchase and sale of 1,000,000 American Depositary Shares (“ADSs”) (or ADS equivalents in lieu thereof), each representing thirty (30) ordinary shares of the Company, at an offering price of US$2.00 per ADS. In addition, in a concurrent private placement, the Company has issued unregistered warrants (“Warrants”) to purchase up to 1,000,000 ADSs. The Warrants have an exercise price of US$2.00 per ADS, are exercisable upon issuance, and will expire five years following issuance. No shareholder approval is required as the capital raising as it is undertaken pursuant to the shareholder approval at the Company’s EGM held on March 20, 2024. H.C. Wain
Show less
Read more
Impact Snapshot
Event Time:
GENE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GENE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GENE alerts
High impacting Genetic Technologies Ltd - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
GENE
News
- Appendix 4C & Quarterly Business Update – March 2024GlobeNewswire
- Genetic Technologies stock tumbles on direct offering pricing [Seeking Alpha]Seeking Alpha
- Genetic Technologies Announces $2 Million Registered Direct Offering [Yahoo! Finance]Yahoo! Finance
- Genetic Technologies Announces $2 Million Registered Direct OfferingGlobeNewswire
- New Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment Outcomes [Yahoo! Finance]Yahoo! Finance
GENE
Sec Filings
- 4/30/24 - Form 6-K
- 4/23/24 - Form 6-K
- 4/23/24 - Form 6-K
- GENE's page on the SEC website